Clinical Trials Directory

Trials / Completed

CompletedNCT03034122

Is Caffeine an Environmental Modifier in Huntington's Disease?

Status
Completed
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to establish if caffeine consumption is associated with the evolution of the disease in premanifest HD.

Conditions

Timeline

Start date
2017-10-11
Primary completion
2024-04-12
Completion
2024-04-12
First posted
2017-01-27
Last updated
2025-12-23

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03034122. Inclusion in this directory is not an endorsement.

Is Caffeine an Environmental Modifier in Huntington's Disease? (NCT03034122) · Clinical Trials Directory